MPAC Group PLC
LSE:MPAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MPAC Group PLC
LSE:MPAC
|
UK |
|
Thermogenesis Holdings Inc
F:THR
|
US |
|
Galapagos NV
AEX:GLPG
|
BE |
|
B
|
Bonvests Holdings Ltd
SGX:B28
|
SG |
|
DSV A/S
CSE:DSV
|
DK |
|
dynaCERT Inc
TSX:DYA
|
CA |
|
D
|
Debao Property Development Ltd
SGX:BTF
|
CN |
|
Pharma Mar SA
MAD:PHM
|
ES |
|
Kelso Technologies Inc
TSX:KLS
|
CA |
|
Vir Biotechnology Inc
NASDAQ:VIR
|
US |
|
America Great Health
OTC:AAGH
|
US |
Wall Street
Price Targets
MPAC Price Targets Summary
MPAC Group PLC
According to Wall Street analysts, the average 1-year price target for
MPAC
is 586.5 GBX
with a low forecast of 555.5 GBX and a high forecast of 630 GBX.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MPAC's stock price target?
Price Target
586.5
GBX
According to Wall Street analysts, the average 1-year price target for
MPAC
is 586.5 GBX
with a low forecast of 555.5 GBX and a high forecast of 630 GBX.
What is MPAC Group PLC's Revenue forecast?
Projected CAGR
15%
For the last 13 years the
compound annual growth rate for
MPAC Group PLC's revenue is
2%.
The projected
CAGR
for the next 3 years is
15%.
What is MPAC Group PLC's Operating Income forecast?
Projected CAGR
27%
For the last 13 years the
compound annual growth rate for
MPAC Group PLC's operating income is
5%.
The projected
CAGR
for the next 3 years is
27%.
What is MPAC Group PLC's Net Income forecast?
Projected CAGR
109%
For the last 13 years the
compound annual growth rate for
MPAC Group PLC's net income is
-12%.
The projected
CAGR
for the next 3 years is
109%.
